Immix Biopharma (IMMX) Payables (2020 - 2026)
Immix Biopharma's Payables came in at $9.19 million for Q2 2026, down 7.5% from $9.94 million a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Immix Biopharma's Payables was $9.97 million, up 15.6% from FY2024.
- Payables has increased in each of the last four years, with a five-year compound annual growth rate of 101.2% (FY2020 to FY2025).
- Going back by year, Payables was $8.62 million in FY2024 (+131.7%), $3.72 million in FY2023 (+192.3%), $1.27 million in FY2022 (+559.9%) and $192,940 in FY2021 (-36.2%).
- The Q2 2026 figure represents the lowest quarterly Payables since Q4 2024.
- Year-over-year, Payables increased in seven of the last eight quarters, with growth averaging 71.2%.
- The fastest year-over-year change in Payables over five years came in Q4 2022 (growth of 559.9%), and the weakest in Q4 2021 (a decline of 36.2%).
- Business Quant data shows IMMX's Payables at $10.41 million (Q1 2026), $9.97 million (Q4 2025) and $10.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - | 9.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.19 Mn |
| Mar 31, 2026 | 10.41 Mn |
| Dec 31, 2025 | 9.97 Mn |
| Sep 30, 2025 | 10.71 Mn |
| Jun 30, 2025 | 9.94 Mn |
| Mar 31, 2025 | 9.24 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 646,457.00 |
| Jun 30, 2022 | 977,209.00 |
| Mar 31, 2022 | 355,679.00 |
| Dec 31, 2021 | 192,940.00 |
| Dec 31, 2020 | 302,344.00 |
API Access
Immix Biopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();